BWX Technologies (BWXT)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-10-29
$130.70-5.24%
Close 2026-10-30 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-10-29
Research Workspace
Put BWXT beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Free cash flow reaches at least $315 million in 2026: Free cash flow guidance: $50M to $80M.
View ThesisRevenue growth is accelerating — up about 23% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 47% in its worst 12-month stretch.
View RiskBWXT's case rests on growing defense and commercial nuclear work, with cash generation central to its appeal. Revenue growth slowed from 26% to 18% year over year, though Q2 FY2026 earnings beat consensus. That quarter's revenue grew 18% year over year, and non-GAAP earnings beat consensus by 5.9%. BWXT trades at 32× P/E versus a 29× peer median; expectations look modest versus our view. The thesis's free-cash-flow pillar is broken: 2026 guidance is $50 million to $80 million against a $315 million threshold. Our model puts the next-quarter miss probability at 18%. Peer multiples imply a price roughly in line with where it trades (about fair); the thesis has broken, and this read is provisional.
Trailing returns as of 2026-10-30. BWXT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering BWXT (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for BWXT in the last 4 months.
Continue this research
Compare BWXT with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BWXT Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put BWXT next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Focus on core nuclear national defense and commercial nuclear power markets
Army selection supports BWXT’s defense-nuclear focus, but the headline alone provides limited deal detail.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $130.70
The last 12 months of price, then the range of analyst 12-month targets from today’s $130.70.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Focus on core nuclear national defense and commercial nuclear power markets
Fuel supply agreement supports BWXT’s commercial nuclear power focus and provides contracted business through 2029.
Advances: Generate strong free cash flow and manage capital expenditures
Upgrade indicates strong cash flow potential and revenue growth.
Advances: Increase revenue growth
New $189 million contract adds defense work and supports revenue visibility.
Advances: Focus on core nuclear national defense and commercial nuclear power markets
Positive credit outlook cites naval strength, reinforcing the defense business's resilience.
Threatens: Increase net income and earnings per share
Earnings estimate cut may impact net income and EPS.
Advances: Focus on core nuclear national defense and commercial nuclear power markets
Strengthens focus on core nuclear markets and growth potential.
Advances: Focus on core nuclear national defense and commercial nuclear power markets
Expansion aligns with focus on core nuclear markets.
